AU659130B2 - Vector - Google Patents

Vector Download PDF

Info

Publication number
AU659130B2
AU659130B2 AU11146/92A AU1114692A AU659130B2 AU 659130 B2 AU659130 B2 AU 659130B2 AU 11146/92 A AU11146/92 A AU 11146/92A AU 1114692 A AU1114692 A AU 1114692A AU 659130 B2 AU659130 B2 AU 659130B2
Authority
AU
Australia
Prior art keywords
gene
vector
sequence
dna
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU11146/92A
Other languages
English (en)
Other versions
AU1114692A (en
Inventor
Peter Thomas Barth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919104017A external-priority patent/GB9104017D0/en
Priority claimed from GB919109188A external-priority patent/GB9109188D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of AU1114692A publication Critical patent/AU1114692A/en
Application granted granted Critical
Publication of AU659130B2 publication Critical patent/AU659130B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Devices For Executing Special Programs (AREA)
  • Image Analysis (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Laser Surgery Devices (AREA)
  • Surgical Instruments (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vending Machines For Individual Products (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU11146/92A 1991-02-26 1992-02-24 Vector Ceased AU659130B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9104017 1991-02-26
GB919104017A GB9104017D0 (en) 1991-02-26 1991-02-26 Vector
GB919109188A GB9109188D0 (en) 1991-04-29 1991-04-29 Vector
GB9109188 1991-04-29

Publications (2)

Publication Number Publication Date
AU1114692A AU1114692A (en) 1992-08-27
AU659130B2 true AU659130B2 (en) 1995-05-11

Family

ID=26298495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11146/92A Ceased AU659130B2 (en) 1991-02-26 1992-02-24 Vector

Country Status (13)

Country Link
US (1) US5840521A (fi)
EP (1) EP0502637B1 (fi)
JP (1) JP3522292B2 (fi)
AT (1) ATE263838T1 (fi)
AU (1) AU659130B2 (fi)
CA (1) CA2061721A1 (fi)
DE (1) DE69233336T2 (fi)
FI (1) FI920835A (fi)
GB (1) GB2253852B (fi)
IE (1) IE920587A1 (fi)
IL (1) IL101058A0 (fi)
NO (1) NO920751L (fi)
NZ (1) NZ241703A (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650085B2 (en) * 1990-11-13 1994-06-09 Immunex Corporation Bifunctional selectable fusion genes
GB9605453D0 (en) 1996-03-15 1996-05-15 Univ Cambridge Tech Cultured cells
GB9715660D0 (en) * 1997-07-25 1997-10-01 Zeneca Ltd Proteins
US6432669B1 (en) 1998-10-07 2002-08-13 Aventis Pasteur Limited Protective recombinant Haemophilus influenzae high molecular weight proteins
WO2000020609A2 (en) * 1998-10-07 2000-04-13 Connaught Laboratories Limited Protective recombinant haemophilus influenzae high molecular weight proteins
WO2001009375A2 (en) * 1999-07-30 2001-02-08 University College London Inducible screen for drug discovery
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
IL159524A0 (en) 2001-07-11 2004-06-01 Maxygen Holdings Ltd G-csf conjugates
GB0602173D0 (en) 2006-02-03 2006-03-15 Avecia Ltd Expression system
AU2007352618B2 (en) 2007-05-02 2013-07-18 Boehringer Ingelheim Animal Health USA Inc. DNA plasmids having improved expression and stability
GB201021795D0 (en) 2010-12-21 2011-02-02 Msd Biolog Uk Ltd Expression Process
CN106574273B (zh) 2014-08-28 2021-07-02 合成生物制品有限公司 β-内酰胺酶的基于大肠杆菌的生产
EP3728292A1 (en) * 2017-12-19 2020-10-28 Syngulon SA Fermentation process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2052516A (en) * 1979-06-01 1981-01-28 Searle & Co Plasmid vectors production and use thereof
AU3102289A (en) * 1988-03-11 1989-09-14 Dana-Farber Cancer Institute, Inc. Regulation of expression in mammalian cells
EP0359379A1 (en) * 1988-07-29 1990-03-21 Eli Lilly And Company A new picromycin resistance-conferring gene, designated picA for use in streptomyces and other organisms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894334A (en) * 1984-03-28 1990-01-16 Cetus Corporation Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
WO1989003886A1 (en) * 1987-10-30 1989-05-05 Oncogen, A Limited Partnership Expression systems for preparation of polypeptides in prokaryotic cells
DE3934454A1 (de) * 1989-10-14 1991-04-18 Merck Patent Gmbh Regulierbare expressionsvektoren fuer bacillus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2052516A (en) * 1979-06-01 1981-01-28 Searle & Co Plasmid vectors production and use thereof
AU3102289A (en) * 1988-03-11 1989-09-14 Dana-Farber Cancer Institute, Inc. Regulation of expression in mammalian cells
EP0359379A1 (en) * 1988-07-29 1990-03-21 Eli Lilly And Company A new picromycin resistance-conferring gene, designated picA for use in streptomyces and other organisms

Also Published As

Publication number Publication date
ATE263838T1 (de) 2004-04-15
GB9203731D0 (en) 1992-04-08
FI920835A0 (fi) 1992-02-25
EP0502637A2 (en) 1992-09-09
NO920751D0 (no) 1992-02-25
FI920835A (fi) 1992-08-27
IE920587A1 (en) 1992-08-26
EP0502637B1 (en) 2004-04-07
IL101058A0 (en) 1992-11-15
DE69233336D1 (de) 2004-05-13
JP3522292B2 (ja) 2004-04-26
AU1114692A (en) 1992-08-27
NZ241703A (en) 1994-07-26
US5840521A (en) 1998-11-24
NO920751L (no) 1992-08-27
GB2253852A (en) 1992-09-23
EP0502637A3 (en) 1992-10-28
CA2061721A1 (en) 1992-08-27
GB2253852B (en) 1995-03-22
JPH0556790A (ja) 1993-03-09
DE69233336T2 (de) 2005-03-31

Similar Documents

Publication Publication Date Title
AU644647B2 (en) Polypeptides
Thisted et al. Mechanism of post-segregational killing by the hok/sok system of plasmid R1: Sok antisense RNA regulates hok gene expression indirectly through the overlapping mok gene
Gardel et al. The secD locus of E. coli codes for two membrane proteins required for protein export.
AU659130B2 (en) Vector
Hofer et al. The superinfection exclusion gene (sieA) of bacteriophage P22: identification and overexpression of the gene and localization of the gene product
Yagil et al. Determinants of site-specific recombination in the lambdoid coliphage HK022: an evolutionary change in specificity
Paddon et al. Expression of Bacillus amyloliquefaciens extracellular ribonuclease (barnase) in Escherichia coli following an inactivating mutation
HU205384B (en) Process for increased expressin of human interleukin-2 in mammal cells
Mikuni et al. Sequence and functional analysis of mutations in the gene encoding peptide-chain-release factor 2 of Escherichia coli
Helftenbein et al. Both α-tubulin genes are transcriptionally active in Stylonchyia lemnae
Schnier et al. The nucleotide sequence of an Escherichia coli chromosomal region containing the genes for ribosomal proteins S6, S18, L9 and an open reading frame
KR100358948B1 (ko) 인체 과립성 백혈구의 콜로니 자극인자를 분비하는 대장균
JPH104981A (ja) 細菌中に含まれるプラスミドの安定化方法
CA1275953C (en) Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof
AU661983B2 (en) Fermentation process
US5840543A (en) Fermentation process
Guzman et al. Transcription of a bacteriophage lambda DNA site blocks growth of Escherichia coli
Wolf Jr Integration of specialized transducing bacteriophage lambda cI857 St68 h80 dgnd his by an unusual pathway promotes formation of deletions and generates a new translocatable element
Riede T-even type phages can change their host range by recombination with gene 34 (tail fibre) or gene 23 (head)
KR900007866B1 (ko) 인간 β-인터페론 유전자를 지닌 대장균 유전자 운반체의 제조방법
EP0309961A1 (en) Plasmid vector containing streptomycin-sensitivity gene
HU216073B (hu) Eljárás sztreptokináz előállítására
KR19980021298A (ko) 섬자리공 항바이러스성 단백질(pip)의 유전자를 이용하는 클로닝벡터